The Impact of Combination Therapy with a-Blockers and 5ARIs on the Progression of BPH

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|16|11|1172-1179

ISSN： 1389-4501

Source： Current Drug Targets, Vol.16, Iss.11, 2015-10, pp. : 1172-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dutasteride + tamsulosin a convincing combination in BPH

By  

Inpharma, Vol. 1, Iss. 1605, 2007-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Combination therapy for HIV: towards long term control of disease progression

By Conway B.   Sékaly R-P.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 6, 1998-06 ,pp. : 941-961

Informa Healthcare

Access to resources Recommend Favorite

Finasteride plus doxazosin combination tops in BPH

By  

Inpharma, Vol. 1, Iss. 1351, 2002-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

PDE-5 Inhibitors for BPH-Associated LUTS

By  

Current Drug Targets, Vol. 16, Iss. 11, 2015-10 ,pp. : 1180-7

Bentham Science Publishers

Access to resources Recommend Favorite

Tamsulosin and dutasteride: winning combination for BPH?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 640, 2011-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite